Ibandronate Sodium Catalog No.:M8787-2 induces apoptosis in NSCLC cells

induces apoptosis in NSCLC cells

InChiKey: CWJJHESJXJQCJA-UHFFFAOYSA-N

InChiKey: WIJZXSAJMHAVGX-DHLKQENFSA-N

Nesland JM

CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C21

Ibandronate Sodium Catalog No.:M8787-2 induces apoptosis in NSCLC cellsIbandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). Ibandronate is indicated for the treatment and prevention of osteoporosis in post menopausal women. In May 2003, the U. S. Food and Drug Administration (FDA) approved